June 21, 2022
People With Rare Diseases Face Challenges, Require Support
In the U.S., orphan diseases are conditions impacting fewer than 200,000 people. There are more…
Read More
June 20, 2022
The win-win-win of the patient-first model
Tiffany Burt President and Chief Operating Officer Optime Care Imagine you’ve just been diagnosed with…
Read More
May 26, 2022
3 Ways The Patient-First Strategy Simplifies Regulatory Compliance
Brandon Salke Pharmacist in Charge, General Manager of Operations Optime Care The FDA establishes strict…
Read More
May 16, 2022
Overcoming Complexity By Choosing an All-Inclusive, Patient-First Specialty Pharmacy Solution
Brandon Salke Pharmacist in Charge, General Manager of Operations Optime Care Specialty Pharmacy Service…
Read More
April 29, 2022
Conquering the Data Disconnect in Rare and Orphan Drugs
Brandon Salke Pharmacist in Charge, General Manager of Operations Optime Care With the right data…
Read More
April 22, 2022
The “Sticky” Revenue Strategy for Rare and Orphan Drugs
Brandon Salke Pharmacist in Charge, General Manager of Operations Optime Care The patient-first service model…
Read More
April 15, 2022
The Patient-First Strategy for Cell and Gene Therapies
Brandon Salke Pharmacist in Charge, General Manager of Operations Optime Care Reengineering cells, repairing or…
Read More
April 11, 2022
Patient-First Strategy Optimizes Diagnostic Journey, Improves Experience for Rare Disease Patients
For many people living with an undiagnosed medical condition, the journey to an official diagnosis…
Read More
April 11, 2022
Telehealth as a Permanent Option in Specialty Pharmacy
Brandon Salke Pharmacist in Charge, General Manager of Operations Optime Care From crisis comes opportunity—if…
Read More
April 4, 2022
The Future of Clinical Trials in the World of Rare Disease
The advent of more flexible clinical trial design brings a promise of greater hope in…
Read More
